nodes	percent_of_prediction	percent_of_DWPC	metapath
Sertraline—CYP1A2—Pentoxifylline—systemic scleroderma	0.0743	0.14	CbGbCtD
Sertraline—CYP1A2—Leflunomide—systemic scleroderma	0.0709	0.133	CbGbCtD
Sertraline—ABCB1—Lisinopril—systemic scleroderma	0.065	0.122	CbGbCtD
Sertraline—CYP2C9—Leflunomide—systemic scleroderma	0.0639	0.12	CbGbCtD
Sertraline—ABCB1—Captopril—systemic scleroderma	0.0487	0.0914	CbGbCtD
Sertraline—CYP2D6—Captopril—systemic scleroderma	0.0459	0.0861	CbGbCtD
Sertraline—ABCB1—Mycophenolate mofetil—systemic scleroderma	0.0383	0.072	CbGbCtD
Sertraline—CYP2C19—Prednisone—systemic scleroderma	0.038	0.0713	CbGbCtD
Sertraline—ABCB1—Prednisone—systemic scleroderma	0.0306	0.0575	CbGbCtD
Sertraline—CYP3A4—Mycophenolate mofetil—systemic scleroderma	0.023	0.0431	CbGbCtD
Sertraline—CYP3A4—Prednisone—systemic scleroderma	0.0184	0.0345	CbGbCtD
Sertraline—ABCB1—Methotrexate—systemic scleroderma	0.0154	0.0289	CbGbCtD
Sertraline—CYP2C9—cardial valve—systemic scleroderma	0.0096	0.413	CbGeAlD
Sertraline—MAOB—connective tissue—systemic scleroderma	0.000851	0.0366	CbGeAlD
Sertraline—SIGMAR1—smooth muscle tissue—systemic scleroderma	0.000813	0.035	CbGeAlD
Sertraline—MAOA—connective tissue—systemic scleroderma	0.000726	0.0312	CbGeAlD
Sertraline—SLC6A4—digestive system—systemic scleroderma	0.000647	0.0278	CbGeAlD
Sertraline—MAOB—digestive system—systemic scleroderma	0.000615	0.0264	CbGeAlD
Sertraline—SIGMAR1—tendon—systemic scleroderma	0.000611	0.0263	CbGeAlD
Sertraline—ABCB1—blood vessel—systemic scleroderma	0.000605	0.026	CbGeAlD
Sertraline—SLC6A3—lung—systemic scleroderma	0.000589	0.0253	CbGeAlD
Sertraline—MAOB—tendon—systemic scleroderma	0.000585	0.0252	CbGeAlD
Sertraline—SLC6A4—lung—systemic scleroderma	0.00054	0.0232	CbGeAlD
Sertraline—SIGMAR1—lung—systemic scleroderma	0.000536	0.0231	CbGeAlD
Sertraline—CYP2C19—digestive system—systemic scleroderma	0.000536	0.023	CbGeAlD
Sertraline—MAOA—digestive system—systemic scleroderma	0.000524	0.0226	CbGeAlD
Sertraline—CYP2B6—skin of body—systemic scleroderma	0.000524	0.0226	CbGeAlD
Sertraline—MAOB—lung—systemic scleroderma	0.000513	0.0221	CbGeAlD
Sertraline—MAOA—tendon—systemic scleroderma	0.000499	0.0215	CbGeAlD
Sertraline—SLC6A2—lung—systemic scleroderma	0.000475	0.0204	CbGeAlD
Sertraline—MAOA—lung—systemic scleroderma	0.000438	0.0188	CbGeAlD
Sertraline—CYP1A2—digestive system—systemic scleroderma	0.000438	0.0188	CbGeAlD
Sertraline—CYP2B6—digestive system—systemic scleroderma	0.000419	0.018	CbGeAlD
Sertraline—CYP2C9—digestive system—systemic scleroderma	0.000415	0.0179	CbGeAlD
Sertraline—CYP1A2—lung—systemic scleroderma	0.000365	0.0157	CbGeAlD
Sertraline—CYP2B6—lung—systemic scleroderma	0.00035	0.0151	CbGeAlD
Sertraline—CYP3A4—digestive system—systemic scleroderma	0.000317	0.0136	CbGeAlD
Sertraline—CYP2D6—digestive system—systemic scleroderma	0.000312	0.0134	CbGeAlD
Sertraline—ABCB1—digestive system—systemic scleroderma	0.000224	0.00964	CbGeAlD
Sertraline—ABCB1—lung—systemic scleroderma	0.000187	0.00805	CbGeAlD
Sertraline—Feeling abnormal—Mycophenolic acid—systemic scleroderma	0.000171	0.000384	CcSEcCtD
Sertraline—Arthralgia—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000384	CcSEcCtD
Sertraline—Chest pain—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000384	CcSEcCtD
Sertraline—Myalgia—Mycophenolate mofetil—systemic scleroderma	0.000171	0.000384	CcSEcCtD
Sertraline—Neuropathy peripheral—Prednisone—systemic scleroderma	0.00017	0.000384	CcSEcCtD
Sertraline—Myocardial infarction—Prednisone—systemic scleroderma	0.00017	0.000384	CcSEcCtD
Sertraline—Breast disorder—Methotrexate—systemic scleroderma	0.00017	0.000384	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Lisinopril—systemic scleroderma	0.00017	0.000383	CcSEcCtD
Sertraline—Anxiety—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000383	CcSEcCtD
Sertraline—Toxic epidermal necrolysis—Methotrexate—systemic scleroderma	0.00017	0.000382	CcSEcCtD
Sertraline—Hypersensitivity—Azathioprine—systemic scleroderma	0.00017	0.000382	CcSEcCtD
Sertraline—Gastrointestinal pain—Mycophenolic acid—systemic scleroderma	0.00017	0.000382	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Mycophenolate mofetil—systemic scleroderma	0.00017	0.000381	CcSEcCtD
Sertraline—Insomnia—Lisinopril—systemic scleroderma	0.000169	0.00038	CcSEcCtD
Sertraline—Discomfort—Mycophenolate mofetil—systemic scleroderma	0.000169	0.00038	CcSEcCtD
Sertraline—Paraesthesia—Lisinopril—systemic scleroderma	0.000168	0.000377	CcSEcCtD
Sertraline—Vomiting—Captopril—systemic scleroderma	0.000168	0.000377	CcSEcCtD
Sertraline—Dry mouth—Mycophenolate mofetil—systemic scleroderma	0.000167	0.000376	CcSEcCtD
Sertraline—Dyspnoea—Lisinopril—systemic scleroderma	0.000167	0.000375	CcSEcCtD
Sertraline—Rash—Captopril—systemic scleroderma	0.000166	0.000374	CcSEcCtD
Sertraline—Dermatitis—Captopril—systemic scleroderma	0.000166	0.000374	CcSEcCtD
Sertraline—Somnolence—Lisinopril—systemic scleroderma	0.000166	0.000374	CcSEcCtD
Sertraline—Headache—Captopril—systemic scleroderma	0.000165	0.000372	CcSEcCtD
Sertraline—Confusional state—Mycophenolate mofetil—systemic scleroderma	0.000165	0.000371	CcSEcCtD
Sertraline—Dyspepsia—Lisinopril—systemic scleroderma	0.000164	0.00037	CcSEcCtD
Sertraline—Body temperature increased—Mycophenolic acid—systemic scleroderma	0.000164	0.000369	CcSEcCtD
Sertraline—Abdominal pain—Mycophenolic acid—systemic scleroderma	0.000164	0.000369	CcSEcCtD
Sertraline—Anaphylactic shock—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000368	CcSEcCtD
Sertraline—Oedema—Mycophenolate mofetil—systemic scleroderma	0.000164	0.000368	CcSEcCtD
Sertraline—Decreased appetite—Lisinopril—systemic scleroderma	0.000162	0.000365	CcSEcCtD
Sertraline—Gastrointestinal disorder—Lisinopril—systemic scleroderma	0.000161	0.000363	CcSEcCtD
Sertraline—Fatigue—Lisinopril—systemic scleroderma	0.000161	0.000362	CcSEcCtD
Sertraline—Shock—Mycophenolate mofetil—systemic scleroderma	0.000161	0.000362	CcSEcCtD
Sertraline—Nervous system disorder—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000361	CcSEcCtD
Sertraline—Thrombocytopenia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000361	CcSEcCtD
Sertraline—Hypersensitivity—Leflunomide—systemic scleroderma	0.00016	0.00036	CcSEcCtD
Sertraline—Pancreatitis—Methotrexate—systemic scleroderma	0.00016	0.00036	CcSEcCtD
Sertraline—Pain—Lisinopril—systemic scleroderma	0.00016	0.000359	CcSEcCtD
Sertraline—Constipation—Lisinopril—systemic scleroderma	0.00016	0.000359	CcSEcCtD
Sertraline—Tachycardia—Mycophenolate mofetil—systemic scleroderma	0.00016	0.000359	CcSEcCtD
Sertraline—Skin disorder—Mycophenolate mofetil—systemic scleroderma	0.000159	0.000358	CcSEcCtD
Sertraline—Bradycardia—Prednisone—systemic scleroderma	0.000159	0.000358	CcSEcCtD
Sertraline—Hyperhidrosis—Mycophenolate mofetil—systemic scleroderma	0.000158	0.000356	CcSEcCtD
Sertraline—Diarrhoea—Azathioprine—systemic scleroderma	0.000157	0.000354	CcSEcCtD
Sertraline—Haemoglobin—Prednisone—systemic scleroderma	0.000157	0.000353	CcSEcCtD
Sertraline—Nausea—Captopril—systemic scleroderma	0.000157	0.000352	CcSEcCtD
Sertraline—Haemorrhage—Prednisone—systemic scleroderma	0.000156	0.000351	CcSEcCtD
Sertraline—Anorexia—Mycophenolate mofetil—systemic scleroderma	0.000156	0.000351	CcSEcCtD
Sertraline—Asthenia—Leflunomide—systemic scleroderma	0.000156	0.000351	CcSEcCtD
Sertraline—Hallucination—Prednisone—systemic scleroderma	0.000155	0.00035	CcSEcCtD
Sertraline—Pancytopenia—Methotrexate—systemic scleroderma	0.000155	0.000348	CcSEcCtD
Sertraline—Feeling abnormal—Lisinopril—systemic scleroderma	0.000154	0.000346	CcSEcCtD
Sertraline—Pruritus—Leflunomide—systemic scleroderma	0.000154	0.000346	CcSEcCtD
Sertraline—Connective tissue disorder—Prednisone—systemic scleroderma	0.000153	0.000345	CcSEcCtD
Sertraline—Hypotension—Mycophenolate mofetil—systemic scleroderma	0.000153	0.000344	CcSEcCtD
Sertraline—Gastrointestinal pain—Lisinopril—systemic scleroderma	0.000153	0.000344	CcSEcCtD
Sertraline—Dysuria—Methotrexate—systemic scleroderma	0.000152	0.000343	CcSEcCtD
Sertraline—Dizziness—Azathioprine—systemic scleroderma	0.000152	0.000342	CcSEcCtD
Sertraline—Upper respiratory tract infection—Methotrexate—systemic scleroderma	0.000152	0.000341	CcSEcCtD
Sertraline—Erectile dysfunction—Methotrexate—systemic scleroderma	0.00015	0.000338	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Mycophenolate mofetil—systemic scleroderma	0.000149	0.000335	CcSEcCtD
Sertraline—Photosensitivity reaction—Methotrexate—systemic scleroderma	0.000149	0.000335	CcSEcCtD
Sertraline—Asthenia—Mycophenolic acid—systemic scleroderma	0.000149	0.000335	CcSEcCtD
Sertraline—Diarrhoea—Leflunomide—systemic scleroderma	0.000149	0.000335	CcSEcCtD
Sertraline—Urticaria—Lisinopril—systemic scleroderma	0.000148	0.000334	CcSEcCtD
Sertraline—Insomnia—Mycophenolate mofetil—systemic scleroderma	0.000148	0.000333	CcSEcCtD
Sertraline—Abdominal pain—Lisinopril—systemic scleroderma	0.000148	0.000332	CcSEcCtD
Sertraline—Body temperature increased—Lisinopril—systemic scleroderma	0.000148	0.000332	CcSEcCtD
Sertraline—Paraesthesia—Mycophenolate mofetil—systemic scleroderma	0.000147	0.000331	CcSEcCtD
Sertraline—Pruritus—Mycophenolic acid—systemic scleroderma	0.000147	0.00033	CcSEcCtD
Sertraline—Vomiting—Azathioprine—systemic scleroderma	0.000146	0.000329	CcSEcCtD
Sertraline—Eye disorder—Prednisone—systemic scleroderma	0.000146	0.000328	CcSEcCtD
Sertraline—Dyspnoea—Mycophenolate mofetil—systemic scleroderma	0.000146	0.000328	CcSEcCtD
Sertraline—Somnolence—Mycophenolate mofetil—systemic scleroderma	0.000145	0.000327	CcSEcCtD
Sertraline—Drowsiness—Methotrexate—systemic scleroderma	0.000145	0.000327	CcSEcCtD
Sertraline—Rash—Azathioprine—systemic scleroderma	0.000145	0.000327	CcSEcCtD
Sertraline—Dermatitis—Azathioprine—systemic scleroderma	0.000145	0.000326	CcSEcCtD
Sertraline—Depression—Methotrexate—systemic scleroderma	0.000145	0.000326	CcSEcCtD
Sertraline—Flushing—Prednisone—systemic scleroderma	0.000145	0.000326	CcSEcCtD
Sertraline—Headache—Azathioprine—systemic scleroderma	0.000144	0.000324	CcSEcCtD
Sertraline—Stevens-Johnson syndrome—Methotrexate—systemic scleroderma	0.000144	0.000324	CcSEcCtD
Sertraline—Dyspepsia—Mycophenolate mofetil—systemic scleroderma	0.000144	0.000324	CcSEcCtD
Sertraline—Dizziness—Leflunomide—systemic scleroderma	0.000144	0.000323	CcSEcCtD
Sertraline—Decreased appetite—Mycophenolate mofetil—systemic scleroderma	0.000142	0.00032	CcSEcCtD
Sertraline—Diarrhoea—Mycophenolic acid—systemic scleroderma	0.000142	0.000319	CcSEcCtD
Sertraline—Stomatitis—Methotrexate—systemic scleroderma	0.000142	0.000319	CcSEcCtD
Sertraline—Angiopathy—Prednisone—systemic scleroderma	0.000142	0.000319	CcSEcCtD
Sertraline—Conjunctivitis—Methotrexate—systemic scleroderma	0.000141	0.000318	CcSEcCtD
Sertraline—Gastrointestinal disorder—Mycophenolate mofetil—systemic scleroderma	0.000141	0.000318	CcSEcCtD
Sertraline—Immune system disorder—Prednisone—systemic scleroderma	0.000141	0.000317	CcSEcCtD
Sertraline—Pain—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000315	CcSEcCtD
Sertraline—Constipation—Mycophenolate mofetil—systemic scleroderma	0.00014	0.000315	CcSEcCtD
Sertraline—Arrhythmia—Prednisone—systemic scleroderma	0.000139	0.000314	CcSEcCtD
Sertraline—Sweating—Methotrexate—systemic scleroderma	0.000139	0.000314	CcSEcCtD
Sertraline—Haematuria—Methotrexate—systemic scleroderma	0.000139	0.000312	CcSEcCtD
Sertraline—Vomiting—Leflunomide—systemic scleroderma	0.000138	0.000311	CcSEcCtD
Sertraline—Alopecia—Prednisone—systemic scleroderma	0.000138	0.00031	CcSEcCtD
Sertraline—Hypersensitivity—Lisinopril—systemic scleroderma	0.000138	0.00031	CcSEcCtD
Sertraline—Hepatobiliary disease—Methotrexate—systemic scleroderma	0.000137	0.000309	CcSEcCtD
Sertraline—Dizziness—Mycophenolic acid—systemic scleroderma	0.000137	0.000309	CcSEcCtD
Sertraline—Epistaxis—Methotrexate—systemic scleroderma	0.000137	0.000308	CcSEcCtD
Sertraline—Rash—Leflunomide—systemic scleroderma	0.000137	0.000308	CcSEcCtD
Sertraline—Dermatitis—Leflunomide—systemic scleroderma	0.000137	0.000308	CcSEcCtD
Sertraline—Mental disorder—Prednisone—systemic scleroderma	0.000137	0.000308	CcSEcCtD
Sertraline—Nausea—Azathioprine—systemic scleroderma	0.000137	0.000308	CcSEcCtD
Sertraline—Headache—Leflunomide—systemic scleroderma	0.000136	0.000306	CcSEcCtD
Sertraline—Malnutrition—Prednisone—systemic scleroderma	0.000136	0.000306	CcSEcCtD
Sertraline—Erythema—Prednisone—systemic scleroderma	0.000136	0.000306	CcSEcCtD
Sertraline—Agranulocytosis—Methotrexate—systemic scleroderma	0.000136	0.000305	CcSEcCtD
Sertraline—Feeling abnormal—Mycophenolate mofetil—systemic scleroderma	0.000135	0.000303	CcSEcCtD
Sertraline—Asthenia—Lisinopril—systemic scleroderma	0.000134	0.000302	CcSEcCtD
Sertraline—Gastrointestinal pain—Mycophenolate mofetil—systemic scleroderma	0.000134	0.000301	CcSEcCtD
Sertraline—Pruritus—Lisinopril—systemic scleroderma	0.000132	0.000297	CcSEcCtD
Sertraline—Vomiting—Mycophenolic acid—systemic scleroderma	0.000132	0.000297	CcSEcCtD
Sertraline—Haemoglobin—Methotrexate—systemic scleroderma	0.000131	0.000295	CcSEcCtD
Sertraline—Rash—Mycophenolic acid—systemic scleroderma	0.000131	0.000294	CcSEcCtD
Sertraline—Dermatitis—Mycophenolic acid—systemic scleroderma	0.000131	0.000294	CcSEcCtD
Sertraline—Hepatitis—Methotrexate—systemic scleroderma	0.00013	0.000294	CcSEcCtD
Sertraline—Haemorrhage—Methotrexate—systemic scleroderma	0.00013	0.000294	CcSEcCtD
Sertraline—Urticaria—Mycophenolate mofetil—systemic scleroderma	0.00013	0.000293	CcSEcCtD
Sertraline—Headache—Mycophenolic acid—systemic scleroderma	0.00013	0.000292	CcSEcCtD
Sertraline—Pharyngitis—Methotrexate—systemic scleroderma	0.00013	0.000291	CcSEcCtD
Sertraline—Abdominal pain—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000291	CcSEcCtD
Sertraline—Body temperature increased—Mycophenolate mofetil—systemic scleroderma	0.000129	0.000291	CcSEcCtD
Sertraline—Nausea—Leflunomide—systemic scleroderma	0.000129	0.000291	CcSEcCtD
Sertraline—Urinary tract disorder—Methotrexate—systemic scleroderma	0.000129	0.00029	CcSEcCtD
Sertraline—Urethral disorder—Methotrexate—systemic scleroderma	0.000128	0.000288	CcSEcCtD
Sertraline—Diarrhoea—Lisinopril—systemic scleroderma	0.000128	0.000288	CcSEcCtD
Sertraline—Ill-defined disorder—Prednisone—systemic scleroderma	0.000126	0.000284	CcSEcCtD
Sertraline—Visual impairment—Methotrexate—systemic scleroderma	0.000126	0.000283	CcSEcCtD
Sertraline—Anaemia—Prednisone—systemic scleroderma	0.000126	0.000283	CcSEcCtD
Sertraline—Agitation—Prednisone—systemic scleroderma	0.000125	0.000281	CcSEcCtD
Sertraline—Angioedema—Prednisone—systemic scleroderma	0.000124	0.000279	CcSEcCtD
Sertraline—Dizziness—Lisinopril—systemic scleroderma	0.000124	0.000278	CcSEcCtD
Sertraline—Erythema multiforme—Methotrexate—systemic scleroderma	0.000123	0.000278	CcSEcCtD
Sertraline—Nausea—Mycophenolic acid—systemic scleroderma	0.000123	0.000277	CcSEcCtD
Sertraline—Malaise—Prednisone—systemic scleroderma	0.000123	0.000276	CcSEcCtD
Sertraline—Vertigo—Prednisone—systemic scleroderma	0.000122	0.000275	CcSEcCtD
Sertraline—Eye disorder—Methotrexate—systemic scleroderma	0.000122	0.000274	CcSEcCtD
Sertraline—Syncope—Prednisone—systemic scleroderma	0.000122	0.000274	CcSEcCtD
Sertraline—Tinnitus—Methotrexate—systemic scleroderma	0.000122	0.000274	CcSEcCtD
Sertraline—Cardiac disorder—Methotrexate—systemic scleroderma	0.000121	0.000272	CcSEcCtD
Sertraline—Hypersensitivity—Mycophenolate mofetil—systemic scleroderma	0.000121	0.000271	CcSEcCtD
Sertraline—Loss of consciousness—Prednisone—systemic scleroderma	0.000119	0.000269	CcSEcCtD
Sertraline—Vomiting—Lisinopril—systemic scleroderma	0.000119	0.000267	CcSEcCtD
Sertraline—Angiopathy—Methotrexate—systemic scleroderma	0.000118	0.000266	CcSEcCtD
Sertraline—Immune system disorder—Methotrexate—systemic scleroderma	0.000118	0.000265	CcSEcCtD
Sertraline—Rash—Lisinopril—systemic scleroderma	0.000118	0.000265	CcSEcCtD
Sertraline—Convulsion—Prednisone—systemic scleroderma	0.000118	0.000265	CcSEcCtD
Sertraline—Dermatitis—Lisinopril—systemic scleroderma	0.000118	0.000265	CcSEcCtD
Sertraline—Mediastinal disorder—Methotrexate—systemic scleroderma	0.000118	0.000265	CcSEcCtD
Sertraline—Asthenia—Mycophenolate mofetil—systemic scleroderma	0.000117	0.000264	CcSEcCtD
Sertraline—Hypertension—Prednisone—systemic scleroderma	0.000117	0.000264	CcSEcCtD
Sertraline—Chills—Methotrexate—systemic scleroderma	0.000117	0.000263	CcSEcCtD
Sertraline—Headache—Lisinopril—systemic scleroderma	0.000117	0.000263	CcSEcCtD
Sertraline—Pruritus—Mycophenolate mofetil—systemic scleroderma	0.000116	0.000261	CcSEcCtD
Sertraline—Myalgia—Prednisone—systemic scleroderma	0.000116	0.00026	CcSEcCtD
Sertraline—Arthralgia—Prednisone—systemic scleroderma	0.000116	0.00026	CcSEcCtD
Sertraline—Anxiety—Prednisone—systemic scleroderma	0.000115	0.000259	CcSEcCtD
Sertraline—Alopecia—Methotrexate—systemic scleroderma	0.000115	0.000259	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic scleroderma	0.000115	0.000259	CcSEcCtD
Sertraline—Discomfort—Prednisone—systemic scleroderma	0.000114	0.000257	CcSEcCtD
Sertraline—Mental disorder—Methotrexate—systemic scleroderma	0.000114	0.000257	CcSEcCtD
Sertraline—Erythema—Methotrexate—systemic scleroderma	0.000114	0.000256	CcSEcCtD
Sertraline—Malnutrition—Methotrexate—systemic scleroderma	0.000114	0.000256	CcSEcCtD
Sertraline—Diarrhoea—Mycophenolate mofetil—systemic scleroderma	0.000112	0.000252	CcSEcCtD
Sertraline—Dysgeusia—Methotrexate—systemic scleroderma	0.000111	0.00025	CcSEcCtD
Sertraline—Nausea—Lisinopril—systemic scleroderma	0.000111	0.00025	CcSEcCtD
Sertraline—Oedema—Prednisone—systemic scleroderma	0.000111	0.00025	CcSEcCtD
Sertraline—Anaphylactic shock—Prednisone—systemic scleroderma	0.000111	0.00025	CcSEcCtD
Sertraline—Back pain—Methotrexate—systemic scleroderma	0.00011	0.000247	CcSEcCtD
Sertraline—Shock—Prednisone—systemic scleroderma	0.000109	0.000246	CcSEcCtD
Sertraline—Nervous system disorder—Prednisone—systemic scleroderma	0.000109	0.000245	CcSEcCtD
Sertraline—Tachycardia—Prednisone—systemic scleroderma	0.000108	0.000244	CcSEcCtD
Sertraline—Dizziness—Mycophenolate mofetil—systemic scleroderma	0.000108	0.000244	CcSEcCtD
Sertraline—Skin disorder—Prednisone—systemic scleroderma	0.000108	0.000242	CcSEcCtD
Sertraline—Hyperhidrosis—Prednisone—systemic scleroderma	0.000107	0.000241	CcSEcCtD
Sertraline—Anorexia—Prednisone—systemic scleroderma	0.000106	0.000238	CcSEcCtD
Sertraline—Ill-defined disorder—Methotrexate—systemic scleroderma	0.000105	0.000237	CcSEcCtD
Sertraline—Anaemia—Methotrexate—systemic scleroderma	0.000105	0.000236	CcSEcCtD
Sertraline—Vomiting—Mycophenolate mofetil—systemic scleroderma	0.000104	0.000234	CcSEcCtD
Sertraline—Rash—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000232	CcSEcCtD
Sertraline—Dermatitis—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000232	CcSEcCtD
Sertraline—Headache—Mycophenolate mofetil—systemic scleroderma	0.000103	0.000231	CcSEcCtD
Sertraline—Malaise—Methotrexate—systemic scleroderma	0.000102	0.00023	CcSEcCtD
Sertraline—Vertigo—Methotrexate—systemic scleroderma	0.000102	0.00023	CcSEcCtD
Sertraline—Leukopenia—Methotrexate—systemic scleroderma	0.000102	0.000229	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Prednisone—systemic scleroderma	0.000101	0.000227	CcSEcCtD
Sertraline—Insomnia—Prednisone—systemic scleroderma	0.0001	0.000226	CcSEcCtD
Sertraline—Paraesthesia—Prednisone—systemic scleroderma	9.96e-05	0.000224	CcSEcCtD
Sertraline—Cough—Methotrexate—systemic scleroderma	9.91e-05	0.000223	CcSEcCtD
Sertraline—Convulsion—Methotrexate—systemic scleroderma	9.84e-05	0.000221	CcSEcCtD
Sertraline—Dyspepsia—Prednisone—systemic scleroderma	9.76e-05	0.00022	CcSEcCtD
Sertraline—Nausea—Mycophenolate mofetil—systemic scleroderma	9.72e-05	0.000219	CcSEcCtD
Sertraline—Myalgia—Methotrexate—systemic scleroderma	9.67e-05	0.000218	CcSEcCtD
Sertraline—Chest pain—Methotrexate—systemic scleroderma	9.67e-05	0.000218	CcSEcCtD
Sertraline—Arthralgia—Methotrexate—systemic scleroderma	9.67e-05	0.000218	CcSEcCtD
Sertraline—Decreased appetite—Prednisone—systemic scleroderma	9.64e-05	0.000217	CcSEcCtD
Sertraline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic scleroderma	9.6e-05	0.000216	CcSEcCtD
Sertraline—Fatigue—Prednisone—systemic scleroderma	9.56e-05	0.000215	CcSEcCtD
Sertraline—Discomfort—Methotrexate—systemic scleroderma	9.56e-05	0.000215	CcSEcCtD
Sertraline—Constipation—Prednisone—systemic scleroderma	9.49e-05	0.000213	CcSEcCtD
Sertraline—Confusional state—Methotrexate—systemic scleroderma	9.35e-05	0.00021	CcSEcCtD
Sertraline—Anaphylactic shock—Methotrexate—systemic scleroderma	9.27e-05	0.000209	CcSEcCtD
Sertraline—Feeling abnormal—Prednisone—systemic scleroderma	9.14e-05	0.000206	CcSEcCtD
Sertraline—Nervous system disorder—Methotrexate—systemic scleroderma	9.09e-05	0.000205	CcSEcCtD
Sertraline—Thrombocytopenia—Methotrexate—systemic scleroderma	9.08e-05	0.000204	CcSEcCtD
Sertraline—Gastrointestinal pain—Prednisone—systemic scleroderma	9.07e-05	0.000204	CcSEcCtD
Sertraline—Skin disorder—Methotrexate—systemic scleroderma	9.01e-05	0.000203	CcSEcCtD
Sertraline—Hyperhidrosis—Methotrexate—systemic scleroderma	8.96e-05	0.000202	CcSEcCtD
Sertraline—Anorexia—Methotrexate—systemic scleroderma	8.84e-05	0.000199	CcSEcCtD
Sertraline—Urticaria—Prednisone—systemic scleroderma	8.81e-05	0.000198	CcSEcCtD
Sertraline—Abdominal pain—Prednisone—systemic scleroderma	8.77e-05	0.000197	CcSEcCtD
Sertraline—Body temperature increased—Prednisone—systemic scleroderma	8.77e-05	0.000197	CcSEcCtD
Sertraline—Hypotension—Methotrexate—systemic scleroderma	8.66e-05	0.000195	CcSEcCtD
Sertraline—Musculoskeletal discomfort—Methotrexate—systemic scleroderma	8.45e-05	0.00019	CcSEcCtD
Sertraline—Insomnia—Methotrexate—systemic scleroderma	8.39e-05	0.000189	CcSEcCtD
Sertraline—Paraesthesia—Methotrexate—systemic scleroderma	8.32e-05	0.000187	CcSEcCtD
Sertraline—Dyspnoea—Methotrexate—systemic scleroderma	8.27e-05	0.000186	CcSEcCtD
Sertraline—Somnolence—Methotrexate—systemic scleroderma	8.24e-05	0.000185	CcSEcCtD
Sertraline—Hypersensitivity—Prednisone—systemic scleroderma	8.17e-05	0.000184	CcSEcCtD
Sertraline—Dyspepsia—Methotrexate—systemic scleroderma	8.16e-05	0.000184	CcSEcCtD
Sertraline—Decreased appetite—Methotrexate—systemic scleroderma	8.06e-05	0.000181	CcSEcCtD
Sertraline—Gastrointestinal disorder—Methotrexate—systemic scleroderma	8e-05	0.00018	CcSEcCtD
Sertraline—Fatigue—Methotrexate—systemic scleroderma	7.99e-05	0.00018	CcSEcCtD
Sertraline—Asthenia—Prednisone—systemic scleroderma	7.96e-05	0.000179	CcSEcCtD
Sertraline—Pain—Methotrexate—systemic scleroderma	7.93e-05	0.000178	CcSEcCtD
Sertraline—Pruritus—Prednisone—systemic scleroderma	7.85e-05	0.000177	CcSEcCtD
Sertraline—Feeling abnormal—Methotrexate—systemic scleroderma	7.64e-05	0.000172	CcSEcCtD
Sertraline—Diarrhoea—Prednisone—systemic scleroderma	7.59e-05	0.000171	CcSEcCtD
Sertraline—Gastrointestinal pain—Methotrexate—systemic scleroderma	7.58e-05	0.000171	CcSEcCtD
Sertraline—Urticaria—Methotrexate—systemic scleroderma	7.37e-05	0.000166	CcSEcCtD
Sertraline—Dizziness—Prednisone—systemic scleroderma	7.34e-05	0.000165	CcSEcCtD
Sertraline—Body temperature increased—Methotrexate—systemic scleroderma	7.33e-05	0.000165	CcSEcCtD
Sertraline—Abdominal pain—Methotrexate—systemic scleroderma	7.33e-05	0.000165	CcSEcCtD
Sertraline—Vomiting—Prednisone—systemic scleroderma	7.05e-05	0.000159	CcSEcCtD
Sertraline—Rash—Prednisone—systemic scleroderma	6.99e-05	0.000157	CcSEcCtD
Sertraline—Dermatitis—Prednisone—systemic scleroderma	6.99e-05	0.000157	CcSEcCtD
Sertraline—Headache—Prednisone—systemic scleroderma	6.95e-05	0.000156	CcSEcCtD
Sertraline—Hypersensitivity—Methotrexate—systemic scleroderma	6.83e-05	0.000154	CcSEcCtD
Sertraline—Asthenia—Methotrexate—systemic scleroderma	6.65e-05	0.00015	CcSEcCtD
Sertraline—Nausea—Prednisone—systemic scleroderma	6.59e-05	0.000148	CcSEcCtD
Sertraline—Pruritus—Methotrexate—systemic scleroderma	6.56e-05	0.000148	CcSEcCtD
Sertraline—Diarrhoea—Methotrexate—systemic scleroderma	6.34e-05	0.000143	CcSEcCtD
Sertraline—Dizziness—Methotrexate—systemic scleroderma	6.13e-05	0.000138	CcSEcCtD
Sertraline—Vomiting—Methotrexate—systemic scleroderma	5.89e-05	0.000133	CcSEcCtD
Sertraline—Rash—Methotrexate—systemic scleroderma	5.85e-05	0.000132	CcSEcCtD
Sertraline—Dermatitis—Methotrexate—systemic scleroderma	5.84e-05	0.000131	CcSEcCtD
Sertraline—Headache—Methotrexate—systemic scleroderma	5.81e-05	0.000131	CcSEcCtD
Sertraline—Nausea—Methotrexate—systemic scleroderma	5.51e-05	0.000124	CcSEcCtD
